This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.
CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022.
West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. The program was enacted into law in April 2017 with the passage of the West Virginia Medical Cannabis Act.
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).
Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Medical cannabis has been legal in Poland since 2017. These products are typically more accessible in larger cities. Poland and cannabis. Poland’s medical cannabis program.
Some of the qualifying health conditions include epilepsy, neuropathic pain, chemotherapy side effects, a need for palliative care, and pain linked to multiple sclerosis, according to France24. Children may be eligible in cases of refractory epilepsy or cancer. Who can get medical cannabis in France? . The defenestration case .
In 2017 , the state made it legal once again to grow hemp in an effort to support the agriculture industry, which is the largest industry in the state. It expanded qualifying conditions and allowed patients to access select THC products through state-licensed dispensaries. It failed in the state House. CBD regulations.
Children with epilepsy don’t quit having seizures because they’re on vacation. In 2017, Florida legislators acknowledged the wealth of peer-reviewed scientific literature supporting the use of medical cannabis through statewide legalization. Click to Sign Petition.
In July, 2017, a joint ministerial decision between the Ministers of Health and Justice legalized medical marijuana in Greece, and changed the classification of cannabis from a Table A drug to a Table B drug. In 2017 , Deputy Minister for Agriculture Yiannis Tsironis called for the legalization of cannabis cultivation for personal use.
These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s.
The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”
Cannabis Therapy Impact on West Virginia Patients Medical marijuana was legalized in West Virginia in 2017, and since then, it has been offering a glimmer of hope to many residents suffering from various medical conditions. How medical marijuana has improved their quality of life.
Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. Shutterstock. It modified Law No.
Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis. .
That doesn’t mean you can’t access a green state’s medical marijuana programs, though. Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy. Amyotrophic lateral Sclerosis. Crohn’s disease.
grams of cannabis in 2017. Despite access restrictions, the government has taken a more relaxed stance towards the usage of medicinal cannabis across the country, which is known for being one of the world’s busiest ports. In December of the following year, he was sentenced to the death penalty.
In 2017, newspapers quoted Duterte’s spokesman that the former was open to approving bills legalising medical cannabis. HB 3961, introduced in 2020 by Congressman Luis Raymund Villafuerte, aims at legalising the local production and export of medical marijuana to make it more accessible and cheaper for Filipinos.
Mexico’s supreme court ordered the health ministry on Wednesday to issue regulation within six months on medical marijuana use, saying its failure to do so after legalization in 2017 had put rights at risk for patients, including children.
Yes, you will be able to upload your records directly to your patient portal which you will receive access to. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. In 2017 Virginia began implementation of in-state production of THC-A and CBD oils.
In 2017, a law was enacted in Virginia that allowed people with specific types of intractable epilepsy to access cannabis oil, as long as they had a doctor certify they needed it and it could help with their condition. Essentially, patients who have access to MMJ in Virginia now cannot be prosecuted for possession of marijuana.
Accessible via Australia’s Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1 (THC 10 CBD 10), mid-range (17), and high THC (25) varieties of 15g bag GMP-Certified medical cannabis will be made available.
Parents of critically ill kids have been the driving force behind the widening of access to medicinal marijuana in the United States , England , and beyond. Maternal wisdom — particularly when it comes to treatments for children with epilepsy, multiple sclerosis, and other health conditions — is hard for policymakers to argue with. .
When Whoopi Goldberg launched a line of cannabis products with her business partner, Maya Elizabeth, the award-winning edibles maker, in 2016, little did they know that their brand of pain relief creams for women would become the fastest growing cannabis brands of 2017.
Virginia legalized some forms of medical marijuana in a very limited way in 2017. This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. Recently, Virginia legalization has changed in several ways.
In 2017, the state legislature expanded the law to include six more medical conditions, later adding intractable pain and posttraumatic stress disorder (PTSD) as qualifying conditions in 2018. Essentially, it’s a way for individuals with these medical conditions to access treatment without fear of breaking the law.
As a beacon of hope for patients in Georgia, an executive director has finally been appointed by the Access to Medical Cannabis Commission to oversee the next stages of development for the state’s medical marijuana program. In five years of program development, patients still have no way to legally purchase the oil within state lines.
West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. This program facilitates access to medical cannabis for individuals suffering from qualifying debilitating conditions.
West Virginia is no exception, as the state has also taken steps to provide patients with access to medical cannabis for various qualifying conditions. West Virginia legalized medical marijuana in 2017 with the passage of the West Virginia Medical Cannabis Act. This card is issued by the West Virginia Office of Medical Cannabis (OMC).
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).
Currently, therapies for common neurological disorders such as concussion, migraine and cluster headache, neuropathic pain syndromes, and chronic epilepsy have limitations, especially when these disorders are associated with chronic psychological challenges.
The rules don’t specify the country of origin of the prescription, but they do require travellers to have accessed the drug through a pharmacist. Under current federal and state legislation, patients suffering from severe health conditions can legally access prescription-based medicinal cannabis in Australia.
I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. What medical marijuana delivery routes and associated products are accessible by Florida patients? . Foley LLP – Medical Marijuana Licensure, June 22, 2017 Update.
Fentanyl fatalities were up 29% in 2017 leading to 75 deaths in comparison to 58 deaths in 2016. In anticipation of an imminent opioid crisis, last year the UK government announced that medical cannabis would be accessible by prescriptions through the NHS—from clinicians and for those with exceptional clinical needs—as of November 2018.
Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.
Since 2017, cannabis, with less than 1.0% CBD-derived epilepsy drug Epidiolex is currently available in Swiss pharmacies as a prescription drug. The bill passed its first debate in March 2018, but in April 2019 this was rescinded over security and access concerns. of THC is legal across Switzerland and widely available.
One of the most common and accessible methods for ingesting THCA is via cannabis tea. For some conditions, like epilepsy, surprisingly small amounts can make a big difference in some individuals. In 2017, I published a series of epilepsy cases, some of which had benefited from the use of THCA. How do people use THCA?
At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.
This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.
As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. The appeal was heard last month by the three-judge panel. .
I am a legal Florida medical marijuana patient since January 2017, as well as a patient educator and vocal advocate. ” She further directly advises that cannabis, or marijuana, is a medicine that an overwhelming majority of Floridians voted for and are constitutionally guaranteed access to as a therapeutic medicine. Eric Stevens.
Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. THC – between 2015 and 2017.
10/8/2017. Luckily there are knowledgeable medical nutrigenomic practitioners (like myself) who are able to advise how to decrease this methylation/cannabis pediatric risk factor, through genetic screening that is accessible to most everyone. Accessed online at: [link]. Neuroscience & Biobehavioral Reviews, May 12, 2017.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content